Perspectives on Selected Myasthenia Gravis Posters and Abstracts From the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)

To participate in this activity, please:

Log in Sign Up

Myasthenia gravis, an autoimmune disease characterized by fluctuating muscle weakness, greatly impacts patients’ functioning and activities of daily living. Important treatment advances continue to be made to reduce patient burden of disease and overcome safety, efficacy, and other limitations of available therapies. Join Nicholas Silvestri, MD, as he reports on research results of some of these advances presented at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting. In addition to describing the methods and results of four studies presented at the meeting, Dr. Silvestri provides his expert comments on the clinical implications of each study. 

This activity is also available as a podcast: You may listen here

Course Credit:

0.75 AMA PRA Category 1 CreditsTM

Dates:

Opens: 2024-11-20
Closes: 2025-11-20

Target Audience:

This activity was developed for neurologists and other clinicians who provide care for patients with myasthenia gravis.

This activity is supported by an educational grant from Alexion Pharmaceuticals, Inc.

Accreditation Information

Accreditation

In support of improving patient care, Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Content Planners

Eugene Cullen, MD (Peer Reviewer)
No significant relationships to disclose.

Lauren Mangan, PharmD (Medical Writer)
No significant relationships to disclose.

Annenberg Center for Health Sciences

Staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant financial relationships to disclose.

All of the financial relationships listed for these individuals have been mitigated.

    Presenting Faculty

  • Nicholas J. Silvestri, MD

    Professor of Neurology
    University at Buffalo Jacobs School of Medicine & Biomedical Sciences
    Buffalo, New York

Learning Objectives

  • Describe the unmet needs of patients with myasthenia gravis
  • Individualize therapy in patients with myasthenia gravis
  • Recognize approved and emerging therapies and their (potential) role for the treatment of patients with myasthenia gravis

Faculty Disclosures

Nicholas J. Silvestri, MD

Advisory Board: Amgen

Consultant: Alexion, Annexon, argenx, Immunovant, Janssen, UCB

Speakers Bureau: Takeda